Montreal Clinical Research Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2007

  1. β-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent δ opioid antagonists

    Journal of Medicinal Chemistry, Vol. 50, Núm. 2, pp. 328-333

1999

  1. Synthesis and binding characteristics of [3H] H-Tyr-Ticψ[CH2-NH] Cha-Phe-OH, a highly specific and stable δ-opioid antagonist

    Peptides, Vol. 20, Núm. 9, pp. 1079-1083

1998

  1. Interaction of agonist peptide [3H]Tyr-D-Ala-Phe-Phe-NH2 with μ- opioid receptor in rat brain and CHO-μ/1 cell line

    Peptides, Vol. 19, Núm. 6, pp. 1091-1098

  2. Side chain methyl substitution in the δ-opioid receptor antagonist TIPP has an important effect on the activity profile

    Journal of Medicinal Chemistry, Vol. 41, Núm. 26, pp. 5167-5176

1995

  1. Synthesis and binding characteristics of tritiated tipp[Φ], a highly specific and stable delta opioid antagonist

    Life Sciences, Vol. 56, Núm. 10

  2. Synthesis of the diastereomers of β-Me-Tyr and β-Me-Phe and their effect on the biological properties of the delta opioid receptor antagonist TIPP

    Letters in Peptide Science, Vol. 2, Núm. 3-4, pp. 190-192

1993

  1. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP

    Life Sciences, Vol. 53, Núm. 5